Head to Head Stocks: Neos Therapeutics, Inc. (NASDAQ:NEOS), Berry Global Group, Inc. (NYSE:BERY)

u.s stocks , earnings estimates

Neos Therapeutics, Inc. (NASDAQ:NEOS)

Neos Therapeutics, Inc. (NASDAQ:NEOS) closed at $1.39 on the last trading session with an decrease of -4.14%, whereas, it previously closed at $1.45. The company has a market capitalization of $69.08 Million. The company traded shares of 283478 on the trading day while its three month average volume stands at 408.78 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) produced diluted EPS of -1.33. The EPS estimate for next year as estimated by analysts is at -0.15 while EPS for next quarter is estimated at -0.17. Earnings per Share growth for this year is reported at 39.8, while the analysts estimated the EPS growth for next year at -0.15% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Neos Therapeutics, Inc. (NASDAQ:NEOS) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Neos Therapeutics, Inc. (NASDAQ:NEOS) stands at 1.28 and Price to Book or P/B for the most recent quarter stands at 69.5. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Neos Therapeutics, Inc. (NASDAQ:NEOS) are reported at 1.3 and 1.5 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Neos Therapeutics, Inc. (NASDAQ:NEOS) stands at -48.4, 494.1 and -73 respectively

The trailing twelve month Revenue of Neos Therapeutics, Inc. (NASDAQ:NEOS) is reported at 53.9 Million with income of -44800000. The outstanding shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) are 49.7 Million. The institutional Ownership of the shares of 60.8 stands at 0.80%, this figure is increased 7.78 in the last six months. The insider ownership for the shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) is ticked at 0.1%, the figure is rose 11.19% in the last six months.

Some other important financial aspects to be discussed here for Neos Therapeutics, Inc. (NASDAQ:NEOS) is the Mean Target Price estimated by the analysts which stands at 10.8. The 52 week high of Neos Therapeutics, Inc. (NASDAQ:NEOS) is placed at 7.05 and 52 week low is standing at 1.29.

Performance wise the shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) fell down -2.8% for the week, it also fell -32.85% for the monthly performance, while for the quarter it went up -33.49%. The shares decrease -30.5% for the half year and plummeted for the Year-To-Date performance. The shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) shrinked -78.62% for the yearly performance.

Berry Global Group, Inc. (NYSE:BERY)

Berry Global Group, Inc. (NYSE:BERY) closed at $50.16 on the last trading session with an decrease of -0.69%, whereas, it previously closed at $50.51. The company has a market capitalization of $6.58 Billion. The company traded shares of 850474 on the trading day while its three month average volume stands at 1.5 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Berry Global Group, Inc. (NYSE:BERY) produced diluted EPS of 2.8. The EPS estimate for next year as estimated by analysts is at 3.94 while EPS for next quarter is estimated at 1.01. Earnings per Share growth for this year is reported at 7.3, while the analysts estimated the EPS growth for next year at 3.94% and Earnings growth for next 5 years stands at 10.03% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 42%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Berry Global Group, Inc. (NYSE:BERY) is at 17.9 while the forward p/e is at 12.74. The P/S or Price to Sales ratio of Berry Global Group, Inc. (NYSE:BERY) stands at 0.82 and Price to Book or P/B for the most recent quarter stands at 4.28. The Price to Free Cash Flow ratio or P/FCF is reported at 9. The quick ratio and the current ratio of Berry Global Group, Inc. (NYSE:BERY) are reported at 1.2 and 2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Berry Global Group, Inc. (NYSE:BERY) stands at 4.5, 28.2 and 9 respectively

The trailing twelve month Revenue of Berry Global Group, Inc. (NYSE:BERY) is reported at 8.05 Billion with income of 376 Million. The outstanding shares of Berry Global Group, Inc. (NYSE:BERY) are 131.18 Million. The institutional Ownership of the shares of 98.5 stands at 0.80%, this figure is increased 0.63 in the last six months. The insider ownership for the shares of Berry Global Group, Inc. (NYSE:BERY) is ticked at 0.15%, the figure is plummeted -16.71% in the last six months.

Some other important financial aspects to be discussed here for Berry Global Group, Inc. (NYSE:BERY) is the Mean Target Price estimated by the analysts which stands at 62.33. The 52 week high of Berry Global Group, Inc. (NYSE:BERY) is placed at 59.16 and 52 week low is standing at 40.50.

Performance wise the shares of Berry Global Group, Inc. (NYSE:BERY) rose up 2.53% for the week, it also fell -1.45% for the monthly performance, while for the quarter it went up -8.78%. The shares increase 4.37% for the half year and flew up for the Year-To-Date performance. The shares of Berry Global Group, Inc. (NYSE:BERY) grew 6.07% for the yearly performance.

You may missed